Profil is an internationally renowned CRO in the field of metabolic diseases, founded in 1999. For many years, we have been working closely with the pharmaceutical industry to develop new drugs for the treatment of diabetes and related diseases. We also intensively support the further development of known active substances. Furthermore, we conduct vital research regarding various other exciting applications such as novel routes of insulin administration or the measurement of blood glucose concentrations. Our many years of experience have enabled us to build up comprehensive scientific know-how and a unique expertise in the field of metabolic diseases. Profil currently employs around 330 people who make an important contribution to improving the quality of life of people with diabetes.
We don’t have any open positions right now.